• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Health Care Supplies


12.177 EUR 0.093 0.76%

As of 03:04:38 ET on 07/30/2014.

Snapshot for Vitrolife AB (VTF)

Open: 12.255 Day's Range: 12.177 - 12.380 Volume: 0
Previous Close: 12.270 52wk Range: 7.610 - 14.970 1-Yr Rtn: +52.66%

Stock Chart for VTF

No chart data available.
  • VTF:GR 12.177
  • 1D
  • 1M
  • 1Y
Interactive VTF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VTF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 29.3898
Relative P/E vs. DAX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2014) 3.8250
Est. PEG Ratio -
Market Cap (M EUR) 241.48
Shares Outstanding (M) 19.83
30 Day Average Volume 25
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.91%
Cash Dividend (SEK) 1.0000
Dividend Ex-Date 05/06/2014
5 Year Dividend Growth 24.22%
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VTF

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for VTF

Vitrolife AB is an international biotechnology corporation. The Company develops, produces, and markets products for creating, prolonging, and improving life. Vitrolife focuses on fertility treatments, cell therapy and tissue engineering, organ transplantation systems, and products base on hyaluronic acid. The Company researches and manufactures in Europe and the United States.

Thomas AxelssonChief Executive OfficerMikael EngblomChief Financial Officer
Christer SilversandChief Scientific OfficerMaria ForssVP:Business Development/Mktg
More Company Profile & Key Executives for VTF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil